Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-003926
Accepted
2024-12-30 00:15:03
Documents
1
Effectiveness Date
2024-12-27

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 610
  Complete submission text file 9999999995-24-003926.txt   1825
Mailing Address 100 SUMMIT DR BURLINGTON MA 01803
Business Address 100 SUMMIT DR BURLINGTON MA 01803 781-439-5551
Neuphoria Therapeutics Inc. (Filer) CIK: 0001191070 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: EFFECT | Act: 33 | File No.: 333-271696 | Film No.: 241586814
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)